Won-Jea Cho Selected Research

Galactosamine

1/2017

Caffeic Acid Cyclohexylamide Rescues Lethal Inflammation in Septic Mice through Inhibition of IκB Kinase in Innate Immune Process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won-Jea Cho Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 09/2002
8	Acute Lung Injury 05/2024 - 01/2023
7	Inflammation (Inflammations) 01/2024 - 01/2016
5	Infections 10/2020 - 05/2012
5	Prostatic Neoplasms (Prostate Cancer) 12/2016 - 08/2012
3	Sepsis (Septicemia) 03/2023 - 01/2017
3	Virus Diseases (Viral Diseases) 01/2022 - 10/2020
2	Ulcerative Colitis 02/2024 - 11/2023
2	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 07/2015
2	Hyperpigmentation 01/2020 - 07/2015
2	Acute Liver Failure (Fulminant Hepatic Failure) 11/2017 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 06/2012 - 02/2008
1	Colitis 05/2024
1	Lung Injury 04/2023
1	Chronic Hepatitis C 10/2020
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Sudden Death 11/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2017
1	Shock 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Rheumatoid Arthritis 01/2016
1	Polycythemia Vera 01/2016
1	Obesity 01/2016
1	Essential Thrombocythemia 01/2016
1	Atherosclerosis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Primary Myelofibrosis (Myelosclerosis) 01/2016
1	Adenocarcinoma 07/2014
1	Skin Diseases (Skin Disease) 08/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2013

Drug/Important Bio-Agent (IBA)

7	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2012 - 01/2010
5	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2010
4	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2024 - 01/2023
3	Therapeutic UsesIBA 05/2024 - 01/2016
3	Cyclophilin AIBA 01/2022 - 12/2015
3	Melanins (Melanin)IBA 01/2020 - 11/2011
3	Phosphotransferases (Kinase)IBA 01/2017 - 11/2010
3	Androgen Receptors (Androgen Receptor)IBA 12/2016 - 08/2012
2	CytokinesIBA 04/2023 - 03/2023
2	Antiviral Agents (Antivirals)IBA 07/2021 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 02/2008
2	trioctyl phosphine oxide (TOPO)IBA 01/2018 - 01/2011
2	AndrogensIBA 12/2016 - 08/2012
2	PyridinesIBA 02/2012 - 05/2010
2	pyridineIBA 03/2010 - 01/2010
1	Dextran SulfateIBA 05/2024
1	4-hydroxycoumarinIBA 05/2024
1	osthol (osthole)IBA 02/2024
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2024
1	AmidesIBA 11/2023
1	SulfonamidesIBA 11/2023
1	AcidsIBA 04/2023
1	Lymphocyte Antigen 96IBA 04/2023
1	diphenyl (biphenyl)IBA 01/2023
1	IndolesIBA 01/2023
1	hexosaminidase CIBA 08/2022
1	tau Proteins (tau Protein)IBA 08/2022
1	VaccinesIBA 07/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	Stem Cell FactorIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 11/2019
1	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 11/2019
1	PoisonsIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017
1	Myeloid Differentiation Factor 88IBA 11/2017
1	Toll-Like Receptor AgonistsIBA 01/2017
1	GalactosamineIBA 01/2017
1	Toll-Like Receptor 4IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	caffeic acidIBA 01/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 12/2016
1	Alanine (L-Alanine)FDA Link 12/2016
1	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2016
1	Proline (L-Proline)FDA Link 12/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2016
1	Selenoprotein PIBA 12/2016
1	Caspase 3 (Caspase-3)IBA 12/2016
1	Tyrosine Kinase InhibitorsIBA 11/2016
1	EnzymesIBA 01/2016
1	BerberineIBA 01/2016
1	Melanocyte-Stimulating Hormones (MSH)IBA 07/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2015
1	diphenylmethylene hydrazinecarbothioamideIBA 07/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014
1	Etoposide (VP 16)FDA LinkGeneric 07/2014
1	CamptothecinIBA 07/2014
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2014
1	LigandsIBA 08/2013
1	daidzeinIBA 08/2013
1	RetinoidsIBA 08/2013
1	TubulinIBA 08/2013
1	Androgen Receptor AntagonistsIBA 04/2013

Therapy/Procedure

7	Therapeutics 11/2023 - 02/2008
1	Punctures 01/2017
1	Ligation 01/2017